Here's How This Vaccine Approval From the FDA Benefits Pfizer

[cafead]

via

• Pfizer's tick-borne encephalitis vaccine, Ticovac, has received approval from the FDA for administration in the U.S.
• With a realistic market of millions of people in the U.S., the vaccine appears to be a new billion-dollar opportunity for Pfizer.
• Aside from Ticovac, Pfizer has a number of other exciting products to drive growth.

article source